Naperville, IL, United States of America

Sarah H Wang

This inventor holds 1 USPTO granted patent. Top assignee: Maxcyte Inc.. Active years: 2011.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 316(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sarah H Wang

Introduction

Sarah H Wang is a notable inventor based in Naperville, IL (US). She has made significant strides in the field of biotechnology, particularly with her work on computerized electroporation techniques. Her innovative approach has the potential to enhance various medical and research applications.

Latest Patents

Sarah holds a patent for her invention titled "Computerized Electroporation - Techniques for Computerized Electroporation." This electroporation apparatus can be controlled according to a variety of user-defined processing protocols. Additionally, it generates a processing log that includes patient or sample-specific information. Users can export this log or a summary of it, and interactive instructions are provided to guide them through the processing protocol steps.

Career Highlights

Sarah is currently employed at MaxCyte Inc., where she continues to develop her innovative ideas. Her work has contributed to advancements in the field of electroporation, which is crucial for various applications in biotechnology and medicine.

Collaborations

Some of her notable coworkers include Sergey Dzekunov and Arthur D Hanson. Their collaboration has likely fostered an environment of innovation and creativity within their projects.

Conclusion

Sarah H Wang's contributions to the field of biotechnology through her patented invention demonstrate her commitment to advancing medical technology. Her work at MaxCyte Inc. and collaborations with other professionals highlight the importance of teamwork in driving innovation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…